e.g. mhealth
Search Results (1 to 10 of 629 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 174 JMIR Cancer
- 132 Journal of Medical Internet Research
- 111 JMIR Research Protocols
- 59 JMIR Formative Research
- 28 JMIR mHealth and uHealth
- 24 JMIR Dermatology
- 19 JMIR Public Health and Surveillance
- 18 JMIR Medical Informatics
- 13 JMIRx Med
- 6 JMIR Human Factors
- 6 JMIR Infodemiology
- 5 JMIR AI
- 5 JMIR Pediatrics and Parenting
- 5 JMIR Serious Games
- 4 Interactive Journal of Medical Research
- 4 Iproceedings
- 3 Journal of Participatory Medicine
- 2 JMIR Aging
- 2 JMIR Bioinformatics and Biotechnology
- 2 JMIR Medical Education
- 2 JMIR Mental Health
- 2 JMIR Perioperative Medicine
- 1 JMIR Biomedical Engineering
- 1 JMIR Cardio
- 1 JMIRx Bio
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Nursing
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Consequently, the development and widespread adoption of effective screening strategies have become paramount in the fight against cancer.
Among these strategies, genetic testing has emerged as a pivotal tool in cancer prevention and early detection [3]. By analyzing an individual’s DNA, genetic testing can identify mutations that may predispose individuals to various forms of cancer [4].
JMIR Cancer 2025;11:e67650
Download Citation: END BibTex RIS
The incidence and mortality rates of cancer are rapidly increasing globally. According to the International Agency for Research on Cancer, there were 19.29 million new cancer cases and 9.96 million cancer deaths worldwide in 2020, and the rise in cancer incidence and mortality rates has resulted in a significant disease burden on people [1]. The diagnosis and long-term treatment of cancer not only cause adversity for patients but also impose psychological stress and burdens on caregivers [2].
JMIR Cancer 2025;11:e67131
Download Citation: END BibTex RIS
However, in the past 3 years, an average of only 216 pediatric patients were diagnosed with cancer annually [5]. This suggests that the remaining 75%‐80% of patients remain undiagnosed and likely do not survive (Figure 1). One example is pediatric leukemia, the most common type of pediatric cancer in this region. Although this malignancy should represent 300‐480 cases (ie, 30%‐40% of all pediatric cancer diagnosis), only 40 cases per year have been seen over the last several years [5].
JMIR Form Res 2025;9:e59776
Download Citation: END BibTex RIS
Both versions of the Pan CAN Patient Registry were designed to assist the pancreatic cancer community in understanding the “Right Track” for any patient with pancreatic cancer: right team, right tests, right treatment, and the opportunity to share their data [6].
J Particip Med 2025;17:e65046
Download Citation: END BibTex RIS
Breast cancer is more commonly diagnosed in older populations, particularly among women aged 65 years and older in wealthier countries. In the United States, the average age of breast cancer diagnosis is 62 years, and in 2020, women aged 70 years and older accounted for 30% of all new cases of the disease [1,2]. In the European Union, women older than 65 years made up about 44% of all breast cancer cases [3].
JMIR Cancer 2025;11:e64000
Download Citation: END BibTex RIS
This clinician-confirmed cancer progression in unstructured text (ie, clinical notes) has been shown to serve as a reasonable surrogate for real-world indicators in ascertaining progression endpoints. This is also more practical for real-world studies than purely RECIST-based approaches [6].
JMIR Cancer 2025;11:e64697
Download Citation: END BibTex RIS
Prostate cancer is the second-most common cancer among men worldwide and the most common urologic malignancy in high-income countries. In 2020, there were an estimated 1,414,000 diagnosed cases and 375,304 deaths related to prostate cancer [1]. It is important to note that prostate cancer can progress without symptoms, leading to missed treatment opportunities [2].
J Med Internet Res 2025;27:e63030
Download Citation: END BibTex RIS
According to the requirements of the Taiwan National Cancer Diagnosis and Treatment Quality Certification, MDT meetings must be held regularly every year to discuss new diagnostic cases. However, the treatment course for patients with cancer is long, and patients are often cared for by different clinical departments.
JMIR Cancer 2025;11:e53887
Download Citation: END BibTex RIS
RPM shows particular promise in the care of cancer [3,4] and cardiovascular diseases [5], as these conditions often require prompt intervention when health issues arise. Together, they account for more than half of global mortality, with 33% attributed to cancer and 18% to cardiovascular diseases [6].
JMIR Res Protoc 2025;14:e60849
Download Citation: END BibTex RIS
According to the World Health Organization (WHO), cancer is one of the leading causes of mortality worldwide. In 2020, approximately 19 million people were diagnosed, and 9.3 million people die each year [1,2]. In the particular context of Chile, a comparable pattern was noted; in the same year, 54,000 cases of cancer were diagnosed, with 28,000 fatalities attributed to the disease annually.
JMIR Hum Factors 2025;12:e60169
Download Citation: END BibTex RIS